New peptides and New combinations of peptides for use in Immunotherapy against acute myeloid leukemia (AML) and other types of cancer.

摘要

The present Invention relates to Peptides, Proteins, Nucleic acids and Cells for use in inmunoterapÉuticos methods.In particular, the present Invention relates to Immunotherapy against cancer.The present Invention also relates to epÍtopos peptÍdicos for tumor Associated T cells alone or in combination with other tumor Associated Peptides, e.g.Can be used as active ingredients in Pharmaceutical compositions, vaccines designed to stimulate antitumor immune responses.To stimulate or ex vivo T lymphocytes that later will be transferred to the patients.The peptides bound to Molecules of the major histocompatibility complex (MHC), or peptides as such can also be targets of Antibodies, T Lymphocyte receptor solubleUnion and other molecules.